Hovione announced on September 6, 2022 that it has expanded its continuous manufacturing offering and services with a new manufacturing line, team, and facility.
The new continuous manufacturing facility is coming online at the Loures site in Portugal. Hovione is also strengthening its capabilities by establishing an experienced, multi-disciplinary global team in continuous tableting. The company is also upgrading its labs with the tools required to support the drug product lifecycle.
